Literature DB >> 7599230

Riboflavin-responsive complex I deficiency.

H R Scholte1, H F Busch, H D Bakker, J M Bogaard, I E Luyt-Houwen, L P Kuyt.   

Abstract

Three patients from a large consanguineous family, and one unrelated patient had exercise intolerance since early childhood and improved by supplementation with a high dosage of riboflavin. This was confirmed by higher endurance power in exercise testing. Riboflavin had been given because complex I, which contains riboflavin in FMN, one of its prosthetic groups, had a very low activity in muscle. Histochemistry showed an increase of subsarcolemmal mitochondria. The low complex I activity contrasted with an increase of the activities of succinate dehydrogenase, succinate-cytochrome c oxidoreductase and cytochrome c oxidase. Isolated mitochondria from these muscle specimens proved deficient in oxidizing pyruvate plus malate and other NAD(+)-linked substrates, but oxidized succinate and ascorbate at equal or higher levels than controls. Two years later a second biopsy was taken in one of the patients, and the activity of complex I had increased from 16% to 47% of the average activity in controls. In the four biopsies, cytochrome c oxidase activity correlated negatively with age. We suspect that this is due to reactive oxygen species generated by the proliferating mitochondria and peroxidizing unsaturated fatty acids of cardiolipin. Three of the four patients had low blood carnitine, and all were found to have hypocarnitinemic family members.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599230     DOI: 10.1016/0925-4439(95)00013-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  A Patient with Complex I Deficiency Caused by a Novel ACAD9 Mutation Not Responding to Riboflavin Treatment.

Authors:  Jessica Nouws; Flemming Wibrand; Mariël van den Brand; Hanka Venselaar; Morten Duno; Allan M Lund; Simon Trautner; Leo Nijtmans; Elsebet Ostergard
Journal:  JIMD Rep       Date:  2013-08-31

2.  Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds.

Authors:  H R Scholte; Y Yu; J D Ross; I I Oosterkamp; A M Boonman; H F Busch
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

3.  Cardiolipin remodeling in a Chinese hamster lung fibroblast cell line deficient in oxidative energy production.

Authors:  A Rusnak; R Mangat; F Xu; G McClarty; G M Hatch
Journal:  J Bioenerg Biomembr       Date:  1997-06       Impact factor: 2.945

4.  Riboflavin and migraine: the bridge over troubled mitochondria.

Authors:  Bruno Colombo; Lorenzo Saraceno; Giancarlo Comi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

5.  Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.

Authors:  D D De Vries; L N Went; G W Bruyn; H R Scholte; R M Hofstra; P A Bolhuis; B A van Oost
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

6.  Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.

Authors:  Pilar Gonzalez-Cabo; Sheila Ros; Francesc Palau
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

7.  Riboflavin prophylaxis in pediatric and adolescent migraine.

Authors:  Maria Condò; Annio Posar; Annalisa Arbizzani; Antonia Parmeggiani
Journal:  J Headache Pain       Date:  2009-08-01       Impact factor: 7.277

8.  Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases.

Authors:  J Panetta; L J Smith; A Boneh
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  High incidence and variable clinical outcome of cardiac hypertrophy due to ACAD9 mutations in childhood.

Authors:  Marie Collet; Zahra Assouline; Damien Bonnet; Marlène Rio; Franck Iserin; Daniel Sidi; Alice Goldenberg; Caroline Lardennois; Metodi Dimitrov Metodiev; Birgit Haberberger; Tobias Haack; Arnold Munnich; Holger Prokisch; Agnès Rötig
Journal:  Eur J Hum Genet       Date:  2015-12-16       Impact factor: 4.246

10.  Riboflavin in cyclic vomiting syndrome: efficacy in three children.

Authors:  Anastasia Martinez-Esteve Melnikova; Michela G Schäppi; Christian Korff
Journal:  Eur J Pediatr       Date:  2015-07-31       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.